Leiomyosarcoma of the Inguinal Canal: A Rare Disease.

J Coll Physicians Surg Pak

Department of Oncology, Dr. Ziauddin Hospital and Ziauddin University, Karachi, Pakistan.

Published: June 2023

Null.

Download full-text PDF

Source
http://dx.doi.org/10.29271/jcpsp.2023.06.713DOI Listing

Publication Analysis

Top Keywords

leiomyosarcoma inguinal
4
inguinal canal
4
canal rare
4
rare disease
4
disease null
4
leiomyosarcoma
1
canal
1
rare
1
disease
1
null
1

Similar Publications

Background: Leiomyosarcoma is a tumor that can develop in any organ that contains smooth muscles. Although leiomyosarcoma is common, its epididymal localization is quite rare.

Case Presentation: A 79-year-old male Chinese Han patient presented with mild pain in the right groin and scrotum for 3 years concomitant with right scrotal swelling.

View Article and Find Full Text PDF
Article Synopsis
  • This case involves a 37-year-old man with both leiomyosarcoma and tenosynovial giant cell tumor, highlighting the difficulties in diagnosing the latter due to biases in clinical assessments.
  • The patient's knee symptoms temporarily worsened after treatments for leiomyosarcoma, which ultimately led to the discovery of the tenosynovial giant cell tumor following further imaging and biopsy.
  • The study emphasizes the need for improved diagnostic strategies and outlines updated treatment guidelines, including novel pharmacological options for managing tenosynovial giant cell tumor effectively.
View Article and Find Full Text PDF

Epididymal leiomyosarcomas are rare malignant tumors of smooth muscle origin. We present a case of a low-grade tumor with negative margins managed with a high-radical inguinal orchiectomy. Our review of the literature suggests that low-grade and localized tumors with negative margins can be managed with simple epididymectomy and imaging surveillance.

View Article and Find Full Text PDF

Purpose: To evaluate the outcomes of adult patients with spermatic cord sarcoma (SCS).

Methods: All consecutive patients with SCS managed by the French Sarcoma Group from 1980 to 2017 were analysed retrospectively. Multivariate analysis (MVA) was used to identify independent correlates of overall survival (OS), metastasis-free survival (MFS), and local relapse-free survival (LRFS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!